GenePlanet Presents its Innovative Health Platform at MEDICA 2018

GenePlanetGenePlanet, the Swiss-backed biotech company present in more than 30 countries worldwide, is attending MEDICA, the leading international trade fair for the medical sector that takes place in Düsseldorf, Germany, from 12-15 November. "Our participation at MEDICA represents a great opportunity to introduce our solutions to a highly-qualified audience. The most important asset people have is their health. We believe GenePlanet can greatly contribute to empowering them to take action to live a healthier lifestyle," commented Marko Bitenc, GenePlanet's CEO.

The company's key innovation is Health Intelligence (Hi!) - a health engagement platform integrating biological data (genetic predispositions, the current status of blood biomarkers and microbiome data) with information from smart devices and wearables to provide recommendations and action plans to improve one’s health and lifestyle.

By setting personal goals and challenges, the user will be able to monitor their progress in specific areas such as nutrition & diet, training & sports, skincare and mental well-being to facilitate long-term behavioural changes that lead to better overall health.

During the event, GenePlanet will also present its successful flagship product, NutriFit - one of the most important players in the field of Nutrigenomics and NutriSkin - a DNA test for personalised skincare and rejuvenation. The company will also show a non-invasive prenatal testing based on cell-free foetal DNA for detection of Down syndrome and other chromosomal abnormalities (NIPT); an accurate test for more than 600 genetic disorders for future parents (Carrier Screen); a test for 87 genetic disorders & 32 medications (Newborn Screen) and Cancer Screen for hereditary cancer risk assessment.

For further information, please visit:
https://geneplanet.com

About GenePlanet

GenePlanet is specialised in genetic testing and related advanced molecular techniques and recognised for offering personalised DNA analyses. By being R&D oriented, the company constantly strives for new discoveries that enables it to provide its clients with the latest and best products developed from its in-house research and development. GenePlanet was established in 2008 in Slovenia by Marko Bitenc, a Silicon Valley Singularity University alumnum, and has just been recognised as the Exporter of the Year 2018 by the public agency SPIRIT Slovenia.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...